...
首页> 外文期刊>Morbidity and Mortality Weekly Report: CDC Surveillance Summaries >Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection a?? Tennessee, 2018
【24h】

Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection a?? Tennessee, 2018

机译:现场注意事项:以前接受过HIV感染的疫苗接种者中的急性A型肝炎病毒感染a?田纳西州,2018

获取原文
           

摘要

Complete immunization against hepatitis A requires 2 doses of a monovalent vaccine or 3 doses of a combined hepatitis A and hepatitis B vaccine; approximately 90% of vaccinated persons achieve protective antibody levels after a single dose of either product (1). However, persons living with human immunodeficiency virus (HIV) infection might not develop the same level of immunity after hepatitis A virus (HAV) vaccination as do immunocompetent persons (2,3). Compared with immunocompetent persons, seroconversion rates among persons with HIV infection are lower and are further affected by CD4 count and HIV viral load at the time of the first dose of vaccine (3). In addition, time to seroconversion is longer (3), and duration of protection wanes earlier (4) among persons with HIV infection. During an outbreak, evaluating predictors of a better vaccine response (CD4 count and HIV viral load at the time of first vaccination) is generally not feasible. Routine assessment of immune response after vaccination is not recommended for persons in general, nor for those with HIV infection (1); therefore, providers use a documented history of HAV vaccination to guide decisions regarding administration of HAV postexposure prophylaxis (PEP). However, compared with vaccination among the general population, a previous hepatitis A vaccination in persons with HIV infection after a high-risk exposure (e.g., household member or sexual contact) might not reliably protect against illness. The Tennessee Department of Health (TDH) sought to determine the frequency at which persons with HIV infection who were previously vaccinated for hepatitis A developed HAV infection during an HAV outbreak.
机译:完全免疫甲肝需要2剂单价疫苗或3剂甲和乙肝联合疫苗。大约90%的接种人员在单剂任一产品后达到保护性抗体水平(1)。但是,人类免疫缺陷病毒(HIV)感染者在接种甲肝病毒(HAV)疫苗后可能无法获得与免疫能力强的人相同的免疫水平(2,3)。与具有免疫能力的人相比,HIV感染者的血清转换率更低,并且在首次接种疫苗时会进一步受到CD4计数和HIV病毒载量的影响(3)。此外,HIV感染者血清转化的时间更长(3),保护期缩短了(4)。在疫情暴发期间,评估更好的疫苗反应(首次接种时的CD4计数和HIV病毒载量)的预测因子通常是不可行的。一般而言,不建议一般人群或艾滋病毒感染者对疫苗接种后的免疫反应进行常规评估(1);因此,提供者应使用已记录的HAV疫苗接种史来指导有关HAV暴露后预防(PEP)管理的决策。但是,与一般人群中的疫苗接种相比,以前在高风险暴露后(例如,家庭成员或性接触)对艾滋病毒感染者进行甲型肝炎疫苗接种可能无法可靠地预防疾病。田纳西州卫生部(TDH)试图确定以前在甲型肝炎暴发期间接受过甲型肝炎疫苗接种的HIV感染者发展为HAV感染的频率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号